Gen-Wealth Partners’s Marvell Technology MRVL Stock Holding History

Gen-Wealth Partners’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.6K	Hold	123	–	–	0.01%	440
2026 Q1	$12.2K	Buy	123 +103	+515%	+$8.65K	﹤0.01%	524
2025 Q4	$1.7K	Hold	20	–	–	﹤0.01%	620
2025 Q3	$1.68K	Hold	20	–	–	﹤0.01%	614
2025 Q2	$1.55K	Buy	+20	New	+$1.25K	﹤0.01%	572

Other funds holding MRVL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gen-Wealth Partners's MRVL Position: Q2 2026 in Review

Gen-Wealth Partners held its Marvell Technology (MRVL) position steady in Q2 2026 at 123 shares worth $36.6K. The position accounts for 0.01% of the portfolio, ranked #440.

Gen-Wealth Partners first reported a position in MRVL in Q2 2025 and has held it in 5 quarters since. 2,217 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

Gen-Wealth Partners held 123 shares of Marvell Technology worth $36.6K as of Q2 2026.
Gen-Wealth Partners left its Marvell Technology share count unchanged in Q2 2026.
Marvell Technology made up 0.01% of Gen-Wealth Partners's portfolio in Q2 2026, its #440 holding.
Gen-Wealth Partners first reported a position in Marvell Technology in Q2 2025 and has held it in 5 quarters since.
2,217 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Gen-Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.